LoginRegister
    Pfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral treatmentPfizer clinches coronavirus vaccine deal with German drugmaker, sees potential in antiviral...
    NPPA fixes prices of 29 formulations under DPCO, check out detailsNPPA fixes prices of 29 formulations under DPCO, check out details
    Bioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung inflammation after COVID-19 infectionBioheaven gets USFDA go ahead to begin phase 2 trial of intranasal vazegepant to treat lung...
    GSK , Vir Biotechnology enter collaboration to find coronavirus solutionsGSK , Vir Biotechnology enter collaboration to find coronavirus solutions
    India should become self-reliant in medical equipment, devices: KasturiranganIndia should become self-reliant in medical equipment, devices: Kasturirangan
    Cancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers SquibbCancer tech Patent Infringment: Gilead Sciences told to pay 1.2 billion dollars to Bristol-Myers...
    Coronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by manufacturersCoronavirus pandemic: Govt delegates more powers to NPPA to control, increase API production by...
    Zydus gets USFDA tentative nod for Empagliflozin TabletsZydus gets USFDA tentative nod for Empagliflozin Tablets
    Dr Reddys Labs receives EIR for Nalgonda-based API plantDr Reddy's Labs receives EIR for Nalgonda-based API plant
    Sanofi to donate 100 million doses of hydroxychloroquine across 50 countriesSanofi to donate 100 million doses of hydroxychloroquine across 50 countries
    Centre steps up efforts to ensure availability of medical oxygenCentre steps up efforts to ensure availability of medical oxygen
    Aurobindo Pharma gets USFDA nod for Fluoxetine TabletsAurobindo Pharma gets USFDA nod for Fluoxetine Tablets
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X